PRZOOM - /newswire/ -
Palo Alto, CA, United States, 2009/03/25 - Fresenius Kabi Oncology, formerly Dabur Pharma, selects MetricStream for Quality and Compliance.
MetricStream, Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, today announced Fresenius Kabi Oncology as a new customer for its quality and compliance management solutions.
Dabur Pharma, a leading company for cancer research and oncology drugs, was renamed Fresenius Kabi Oncology after its acquisition by Fresenius Kabi, the leader in infusion therapy and clinical nutrition in Europe, Latin America, Asia Pacific as well as in the US, where it is a leading supplier of IV generic drugs. Fresenius Kabi has more than 20,000 employees worldwide achieved sales of € 2,030 million in 2007.
“We are pleased to have Fresenius Kabi Oncology as a customer,” said Shankar Bhaskaran, Senior Director and Head of International at MetricStream. “We look forward to working with Fresenius Kabi Oncology to make this initiative a success.”
Deployed at major life science companies across the globe, MetricStream provides an industry leading platform to drive regulatory compliance and quality management programs through configurable workflows, real-time reporting and embedded best practices.
MetricStream (metricstream.com) is a market leader in Enterprise-wide Governance, Risk, Compliance (GRC) and Quality Solutions for global corporations. MetricStream solutions are used by leading corporations such as Pfizer, Philips, NASDAQ, Sandisk, BP, Entergy, Subway, Fairchild Semiconductor, Hitachi and TaylorMade-Adidas Golf in diverse industries such as Pharmaceuticals, Medical Devices, Automotive, Food, High Tech Manufacturing, Energy and Financial Services to manage their quality processes, regulatory and industry-mandated compliance and corporate governance initiatives, as well as by over a million compliance professionals worldwide via the complianceonline.com portal. MetricStream is headquartered in Palo Alto, California.